On March 10, leading domestic AI healthcare company YIDU TECH (02158) officially launched its clinical evidence-based intelligent agent, "YIDU Smart EBM." This mini-program is designed as an "evidence-based assistant" specifically for doctors. It addresses the real-world needs of physicians in clinical diagnosis, treatment, and research scenarios, breaking down the traditional barriers to accessing medical knowledge. The tool allows doctors to quickly obtain efficient decision-making support for their clinical and research work without getting bogged down in literature reviews and evidence appraisal, freeing up valuable time for professional development and skill enhancement, thereby promoting the transition of clinical practices towards intelligent and evidence-based models. "YIDU Smart EBM" is now available for use. During a week-long internal testing period, it attracted enthusiastic participation from over 6,000 medical professionals and garnered nearly 2,000 high-quality, valid feedback responses, with its practicality and professionalism receiving high recognition within the industry.

The foundation of "YIDU Smart EBM" is evidence-based knowledge; it is more than just a tool, it is a reliable "evidence-based platform." The core value of a true clinical-grade AI lies in its professionalism and trustworthiness. Built on a rigorous evidence evaluation system, "YIDU Smart EBM" distills a high-quality knowledge base from vast medical resources, ensuring every piece of knowledge is traceable to professional sources. Importantly, it is not a static knowledge repository; it continuously tracks the latest research and findings from top-tier journals such as NEJM, The Lancet, and JAMA, addressing the issue of delayed updates common in traditional knowledge bases.

Every statement is traceable, making evidence levels clear at a glance. When a doctor poses a question to "YIDU Smart EBM," the system does not simply retrieve a pre-formed answer. Instead, it automatically executes a complete process of evidence retrieval, grading assessment, and logical integration in the background. The result presented to the doctor is a clearly structured, rigorously annotated evidence-based response. Every conclusion is accompanied by a clear source, with the system providing references to corresponding guidelines or literature, allowing doctors to verify the original material with one click. This not only builds trust in the AI but also provides traceable evidence for medical quality assurance, clinical teaching, and complex case discussions. Each answer is sorted by evidence level. Based on systems like GRADE, the system automatically assesses the authority and timeliness of evidence, presenting answers strictly according to the weight of the evidence level. This eliminates the need for doctors to manually sift through information quality, leading to more effortless and precise decision-making.

The tool is designed for practical, scenario-based integration, enabling AI to truly enter clinical workflows. Clinical questions often span multiple specialties and scenarios, making general-purpose AI difficult to adapt to specific needs. "YIDU Smart EBM" features a built-in multi-specialty intelligent agent distribution engine that can intelligently identify the specialty attributes and clinical intent of a question, automatically routing it to the corresponding specialist agent. Each specialist agent is deeply trained on high-quality data within its field, achieving "specialty-specific, precise adaptation" to ensure responses are more aligned with clinical reality and professional standards.

In addition to a general version, "YIDU Smart EBM" offers a hospital-specific version. While strictly adhering to data security and compliance, this version can be deeply integrated with a hospital's existing information systems. By incorporating individual patient treatment data, it can output more targeted, personalized evidence-based recommendations. Currently, "YIDU Smart EBM" has undergone deep clinical validation in hospitals such as Sun Yat-sen University Cancer Center, covering 15 core cancer types including lung cancer, breast cancer, liver cancer, and colorectal cancer. According to the company, an APP version of "YIDU Smart EBM" will also be launched soon, promising more features and a more comprehensive user experience.

In an era of information overload, the scarcest resource for doctors is not knowledge, but time. What "YIDU Smart EBM" achieves is not merely shortening the distance between a "question" and an "answer," but also returning precious time to physicians, empowering healthcare advancement through intelligent, evidence-based support.